Primecap Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.88B | Buy |
|
|||||
2025
Q1 | $2.99B | Sell |
|
|||||
2024
Q4 | $2.69B | Sell |
|
|||||
2024
Q3 | $3.27B | Sell |
|
|||||
2024
Q2 | $3.32B | Sell |
|
|||||
2024
Q1 | $2.91B | Sell |
|
|||||
2023
Q4 | $2.9B | Sell |
|
|||||
2023
Q3 | $2.97B | Sell |
|
|||||
2023
Q2 | $3.15B | Sell |
|
|||||
2023
Q1 | $3.15B | Buy |
|
|||||
2022
Q4 | $3.05B | Sell |
|
|||||
2022
Q3 | $2.5B | Sell |
|
|||||
2022
Q2 | $3.03B | Sell |
|
|||||
2022
Q1 | $3.07B | Sell |
|
|||||
2021
Q4 | $2.72B | Sell |
|
|||||
2021
Q3 | $2.9B | Sell |
|
|||||
2021
Q2 | $2.92B | Sell |
|
|||||
2021
Q1 | $2.48B | Sell |
|
|||||
2020
Q4 | $2.5B | Sell |
|
|||||
2020
Q3 | $2.82B | Sell |
|
|||||
2020
Q2 | $2.84B | Sell |
|
|||||
2020
Q1 | $2.53B | Sell |
|
|||||
2019
Q4 | $2.93B | Sell |
|
|||||
2019
Q3 | $2.62B | Buy |
|
|||||
2019
Q2 | $2.4B | Buy |
|
|||||
2019
Q1 | $2.28B | Buy |
|
|||||
2018
Q4 | $2.13B | Buy |
|
|||||
2018
Q3 | $2.19B | Buy |
|
|||||
2018
Q2 | $1.86B | Buy |
|
|||||
2018
Q1 | $1.8B | Buy |
|
|||||
2017
Q4 | $1.6B | Buy |
|
|||||
2017
Q3 | $1.47B | Buy |
|
|||||
2017
Q2 | $1.29B | Buy |
|
|||||
2017
Q1 | $1.07B | Buy |
|
|||||
2016
Q4 | $710M | Buy |
|
|||||
2016
Q3 | $569M | Buy |
|
|||||
2016
Q2 | $464M | Buy |
|
|||||
2016
Q1 | $368M | Buy |
|
|||||
2015
Q4 | $33.6M | Buy |
|
|||||
2015
Q3 | $5.85M | Buy |
|